PRESS RELEASE published on 06/24/2026 at 18:00, 3 months 1 day ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC. Oxurion bouwt platform voor klinisch onderzoek en software Transparantiekennisgeving Euronext Brussel Oxurion NV Atlas Special Opportunities II LLC Klinisch Onderzoek
BRIEF published on 06/19/2026 at 15:50, 3 months 6 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Technology Platform Atlas Special Opportunities Oxurion
BRIEF published on 06/19/2026 at 15:50, 3 months 6 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actionnariat Plateforme Technologique Notification De Transparence Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 06/19/2026 at 15:45, 3 months 6 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV erhält Transparenzbenachrichtigung gemäß belgischen Vorschriften. Atlas Special Opportunities II LLC informiert über Anteilsverkauf Oxurion NV Belgien Transparenzbenachrichtigung Aktienverkauf Klinischer Forschungsplattform
PRESS RELEASE published on 06/19/2026 at 15:45, 3 months 6 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership percentage Transparency Notification Euronext Brussels Share Ownership Oxurion NV Atlas Special Opportunities II LLC
BRIEF published on 06/15/2026 at 19:35, 3 months 10 days ago Oxurion : Exagis adopté par Pierre Fabre Biopharmaceutique Données Cliniques Oxurion Exagis Pierre Fabre
BRIEF published on 06/15/2026 at 19:35, 3 months 10 days ago Oxurion's Exagis Platform Gains Major Market Validation with Pierre Fabre Laboratories Data Management Pharmaceutical Oxurion Pierre Fabre Exagis Platform
BRIEF published on 06/15/2026 at 19:35, 3 months 10 days ago Oxurion: Exagis adopted by Pierre Fabre Biopharmaceutical Clinical Data Oxurion Exaggerate Pierre Fabre
BRIEF published on 06/15/2026 at 19:35, 3 months 10 days ago La plateforme Exagis d'Oxurion obtient une validation majeure du marché avec les laboratoires Pierre Fabre. Gestion Des Données Pharmaceutique Oxurion Pierre Fabre Plateforme Exagis
PRESS RELEASE published on 06/15/2026 at 19:30, 3 months 10 days ago Belangrijke marktvalidatie: Laboratoires Pierre Fabre gebruiken het Exagis-platform van Oxurion Oxurion NV kündigt die Nutzung von Exagis durch Laboratoires Pierre Fabre an, was die Wertproposition des klinischen Datenmanagementsystems validiert Oxurion NV Exagis Laboratoires Pierre Fabre Klinische Datenmanagement Validierung
Published on 09/26/2026 at 01:00, 6 hours 38 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 6 hours 38 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 9 hours 23 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 14 hours 8 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 16 hours 38 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 00:01, 7 hours 37 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 13 hours 8 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 13 hours 38 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 14 hours 8 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:45, 13 hours 53 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 13 hours 58 minutes ago Availability of the 2026 half-year financial report
